AI Stocks With Real Revenue Growth Investors May Want To Watch

Oil-driven inflation is putting central banks back in the spotlight and keeping borrowing costs a key concern for many companies. At the same time, AI-related demand is helping support growth in places like Singapore, which shows how powerful this theme can be even when conditions feel mixed. This article looks at three AI Stocks screener picks that sit at the heart of this shift.

The three AI stocks featured next are only a starting sample. The broader screen surfaced 15 more companies with equally compelling AI narratives that are not covered here.

If you want to quickly identify and analyze the highest conviction AI plays tied to semiconductors, software and cloud, head straight into the Artificial Intelligence/ AI Stocks screener.

Xero (ASX:XRO)

Xero is a cloud accounting platform that helps small businesses handle bookkeeping, payroll, payments and tax through a single online system, supported by add ons like Planday for scheduling and Hubdoc for document capture. The company generates all its NZ$2.75b in revenue from providing online solutions for small businesses and their advisors. Xero is a large player in this niche, with a market value of about A$13.5b.

Investors keeping an eye on AI in real economy workflows may consider Xero within that context. The core business already serves millions of small businesses, and management is expanding agent powered accounting tools such as the JAX platform and XeroForce, alongside deep integrations with Anthropic’s Claude and Microsoft 365 Copilot. At the same time, the stock trades on a very high P/E multiple, which increases the focus on Xero’s ability to lift margins after last year’s earnings decline. The combination of AI product development and execution risk around profitability makes this a company that some investors may choose to watch closely.

Xero’s AI push in small business accounting is accelerating, yet the real story lies in how that ambition aligns with margins, valuation and execution risk. Get the full picture in the analysis report for Xero

Build your own AI accounting and workflow shortlist

Xero and the other two AI stocks here all came from the same kind of screener, but the real edge comes when you shape the filters yourself. Use our flexible Screener to mix valuation, growth and quality signals for your own watchlist, or tap straight into our curated Investing Ideas.

CAR Group (ASX:CAR)

CAR Group runs online marketplaces that connect car buyers, sellers and dealers, and also sells data, software and advertising services that support the broader auto ecosystem. It generates most of its roughly A$1.25b in revenue from Australia at about A$518 million, with sizeable contributions from North America at about A$327 million and Latin America at about A$253 million, while Asia and Investments add smaller but meaningful streams. The stock is a large mid cap in the local context with a market value around A$11.1b.

CAR Group is attracting interest because it sits at the intersection of AI, data and real world car buying. The company is using AI for inspections, lead management and customer journeys, while also lifting revenue and net income in FY2026 and guiding to double digit revenue growth again in FY2027. That combination of AI driven product development, subscription style revenues and improving margins appeals to many investors, yet it comes with real questions around high debt, dividend coverage and rising competition from global platforms and car makers. The key issue is whether the current valuation and earnings profile fairly reflect both the growth potential and these pressures, or if the market is still mispricing the next phase of CAR Group’s story.

CAR Group’s AI story and subscription revenues may appear to tell you everything, but they do not. To understand the full picture on growth, debt and competition, explore the 3 key rewards and 2 important warning signs

Echo IQ (ASX:EIQ)

Echo IQ is a Sydney based health tech company that uses AI to help cardiologists and oncologists assess the risk of structural heart disease. Its EchoSolv platform currently generates about A$0.09 million in revenue from the development of artificial intelligence software, so the business is still early stage relative to its market value of about A$1.17b.

Echo IQ operates at the intersection of AI, cardiology and oncology. This helps explain why the recent research collaboration with Mayo Clinic and the appointment of a seasoned healthcare CFO are attracting attention. Analysts have published expectations for very strong revenue growth and see potential upside in the share price, yet the company is still loss making, carries a very high P/B multiple and has a volatile share price. For investors, the key consideration is how this combination of tiny revenues, ambitious clinical work and governance questions fits together as the story develops.

Echo IQ sits at the crossroads of AI, cardiology and oncology, yet its tiny A$0.09 million revenue and A$1.17b valuation suggest investors may be missing a key piece. See how expectations around analyst forecasts for Echo IQ could be masking one crucial twist that changes the risk reward picture.

Seeking Fresh Alternatives Before They Fly

Markets move fast and the best breakout ideas rarely stay under the radar for long. Scan these fresh stock lists before momentum is fully caught by the crowd.

• Target dependable income while rates stay uncertain by reviewing a curated group of high yield companies through the 5 dividend fortresses.
• Hunt for under the radar compounders by checking a carefully filtered 11 high quality undiscovered gems that screens for quality, cash flow strength and clean balance sheets.
• Position ahead of the next infrastructure cycle and track potential beneficiaries with a focused 36 power grid technology and infrastructure stocks that zeroes in on grid technology and upgrade plays.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com